Skip to main content
. 2021 Apr 14;40(9):1919–1924. doi: 10.1007/s10096-021-04240-3

Table 2.

Clinical characteristics of cases of IE within the HACEK genera

Haemophilus n = 24 Aggregatibacter n = 49 Cardiobacterium n = 13 Eikenella n = 3 Kingella n = 7
Age, years, median 47 (30–60) 67 (55–73)*** 64 (53–75) 69 (60–69) 59 (32–65)
Gender (% m) 14 (58) 33 (67) 13 (100) 3 (100) 5 (71)
Number of definite IE 23 (96) 44 (90) 8 (62) 2 (67) 6 (86)
Underlying disease
Diabetes 1 (4.2) 3 (6.1) 0 (0) 0 (0) 1 (14)
Cancer 0 (0) 2 (4.1) 0 (0) 0 (0) 0 (0)
Underlying heart disease
Native valve disease 9 (38) 11 (22) 2 (15) 2 (67) 2 (29)
Prosthetic heart valve 7 (29) 16 (33) 7 (54) 2 (67) 2 (29)
Previous IE 2 (8.3) 2 (4.1) 3 (23) 1 (33) 1 (14)
Pacemaker/ICD 4 (17) 13 (27) 2 (15) 0 (0) 1 (14)
Predisposing factors for IE 17 (71) 36 (73) 10 (77) 2 (67) 4 (57)
Type of infection
NVE, left isolated 12 (50) 19 (39) 6 (46) 1 (33) 5 (71)
NVE, right isolated 1 (4.2) 2 (4.1) 0 (0) 0 (0) 0 (0)
NVE, double sided 0 (0) 1 (2.1) 0 (0) 0 (0) 0 (0)
PVE 8 (33) 15 (30) 7 (54) 2 (67) 2 (29)
CIED 3 (13) 12 (24) 0 (0) 0 (0) 1 (14)
Location of acquisition
Community 23 (96) 46 (94) 13 (100) 2 (67) 7 (100)
Nosocomial 0 (0) 3 (6.1) 0 (0) 1 (33) 0 (0)
Health care associated 1 (4.2) 0 (0) 0 (0) 0 (0) 0 (0)
Course of disease
Onset to hospitalization, d 7 (5–38) 19 (5–15) 16 (2–68) 2 (0–4) 7 (4–13)
Length of stay, d 31 (28–36) 33 (22–42) 33 (22–52) 42 (18–86) 25 (14–37)
Treatment length, d 34 (28–42) 32 (29–43) 30 (28–42) 42 (0–70) 28 (25–42)
Embolization 6 (22) 10 (22) 3 (23) 1 (33) 0 (0)
Surgery 11 (40) 14 (30) 8 (62) 0 (0) 3 (43)
Mortality 0 (0) 1 (2.1) 1 (7.7) 0 (0) 0 (0)

Interquartile range (IQR) is presented in brackets when continuous variables are presented. Categorical data are presented as n (%), and continuous data are presented as median. Statistical analyses were done by comparing Haemophilus and Aggregatibacter. For categorical variables Chi2 or Fisher’s exact test was used, and for continuous variables the Mann-Whitney U test was used

IE infective endocarditis, SRIE Swedish Registry of Infective Endocarditis, IQR interquartile range, ICD implantable cardioverter defibrillator, NVE native valve endocarditis, PVE prosthetic valve endocarditis, CIED cardiac implantable electronic device infection, Mortality death during hospital treatment.

***p ≤ 0.001